Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Wonhwa Lee, June Hong Ahn, Hee Ho Park, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Santhamani Ramasamy, Selvakumar Subbian
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 239
Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases
Yongfeng Song, Junjun Liu, Ke Zhao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 10, pp. 1911-1925
Open Access | Times Cited: 200
Low HDL and high triglycerides predict COVID-19 severity
L. Masana, Eudald Correig, Daiana Ibarretxe, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 174
Dissecting lipid metabolism alterations in SARS-CoV-2
Ilaria Casari, Marcello Manfredi, Pat Metharom, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101092-101092
Open Access | Times Cited: 108
Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections
Thierry Gauthier, Wanjun Chen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications
Eva Kočar, Tadeja Režen, Damjana Rozman
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1866, Iss. 2, pp. 158849-158849
Open Access | Times Cited: 137
Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study
Sébastien Tanaka, Christian de Tymowski, Maksud Assadi, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0239573-e0239573
Open Access | Times Cited: 76
Coronavirus Infection and Cholesterol Metabolism
Jun Dai, Huan Wang, Ying Liao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3417-3417
Open Access | Times Cited: 41
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 34
A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes
Shanshan Yang, Chengyu Liu, Mengmeng Jiang, et al.
Protein & Cell (2023) Vol. 15, Iss. 2, pp. 98-120
Open Access | Times Cited: 28
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 9
Metabolic Reprogramming in COVID-19
Tao Shen, Tingting Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11475-11475
Open Access | Times Cited: 49
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows
Michele Mussap, Vassilios Fanos
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 12, pp. 1891-1905
Open Access | Times Cited: 43
Cholesterol metabolism in the regulation of inflammatory responses
Rebekka Bauer, Bernhard Brüne, Tobias Schmid
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions
Rebecca Salomão, Victória Assis, Ivo Vieira de Sousa Neto, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 843-843
Open Access | Times Cited: 17
Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis
Eugenio Hardy, Carlos Fernández-Patrón
Biomolecules (2021) Vol. 11, Iss. 3, pp. 390-390
Open Access | Times Cited: 41
Understanding protection from SARS-CoV-2 using metabolomics
E. Barberis, Elia Amede, Matteo Tavecchia, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 34
LCN2 Mediates Skin Inflammation in Psoriasis through the SREBP2‒NLRC4 Axis
Jingyi Ma, Jiaoling Chen, Ke Xue, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 8, pp. 2194-2204.e11
Closed Access | Times Cited: 24
COVID-19 inflammation and implications in drug delivery
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 260-274
Open Access | Times Cited: 24
VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
Jairo R. Temerozo, Carolina Q. Sacramento, Natália Fintelman-Rodrigues, et al.
Journal of Leukocyte Biology (2022) Vol. 111, Iss. 5, pp. 1107-1121
Open Access | Times Cited: 23
Plasma metabolomics and gene regulatory networks analysis reveal the role of nonstructural SARS-CoV-2 viral proteins in metabolic dysregulation in COVID-19 patients
В. А. Иванисенко, E. V. Gaisler, N. V. Basov, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation
Vinícius Cardoso Soares, Suelen da Silva Gomes Dias, Julia Santos, et al.
Life Science Alliance (2023) Vol. 6, Iss. 11, pp. e202302049-e202302049
Open Access | Times Cited: 15
How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
Nabil G. Seidah, Antonella Pasquato, Ursula Andréo
Viruses (2021) Vol. 13, Iss. 7, pp. 1229-1229
Open Access | Times Cited: 30
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
Maria Proto, Donatella Fiore, Chiara Piscopo, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101099-101099
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top